Patents Assigned to Oxsonics Limited
  • Patent number: 10918718
    Abstract: The invention disclosed herein relates to a method of cavitation-induced delivery of a therapeutic or diagnostic agent to a human or animal subject. In particular the invention provides an agent for use in a method of diagnosis or treatment of a human or animal subject, the method comprising exposing the subject to ultrasound, wherein the agent comprises a therapeutic or diagnostic component which is covalently bound to a dense component, the dense component having a density greater than that of the therapeutic or diagnostic component, and wherein either the dense component is a cavitation initiator or the method comprises administering to the subject a further agent which is a cavitation initiator. Binding of the dense component enhances cavitation-induced transport of the therapeutic or diagnostic component.
    Type: Grant
    Filed: October 21, 2014
    Date of Patent: February 16, 2021
    Assignee: Oxsonics Limited
    Inventors: Steven Mo, Robert Crispin Carlisle, Leonard W. Seymour, Constantin-Cassios Coussios
  • Patent number: 10441529
    Abstract: The invention disclosed herein relates to a nanoparticle comprising: a cup having a cavity, and a gas pocket present in the cavity, wherein the gas pocket is partially encapsulated by the cup. Typical uses of the nanocups include initiating inertial cavitation during simultaneous exposure to ultrasound, and/or as drug carriers to achieve targeted drug delivery in response to ultrasound excitation.
    Type: Grant
    Filed: November 19, 2014
    Date of Patent: October 15, 2019
    Assignee: Oxsonics Limited
    Inventors: James Kwan, Rachel Myers, Constantin-Cassios Coussios, Apurva Shah